Fiera Capital Corp Decreases Holdings in IRadimed Co. (NASDAQ:IRMD)

Fiera Capital Corp cut its stake in shares of IRadimed Co. (NASDAQ:IRMD) by 5.6% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 28,334 shares of the medical equipment provider’s stock after selling 1,680 shares during the period. Fiera Capital Corp owned about 0.22% of IRadimed worth $1,353,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in the stock. Advisor Group Holdings Inc. grew its position in shares of IRadimed by 82.3% during the 1st quarter. Advisor Group Holdings Inc. now owns 2,167 shares of the medical equipment provider’s stock valued at $98,000 after acquiring an additional 978 shares during the period. MetLife Investment Management LLC grew its position in shares of IRadimed by 56.0% during the 1st quarter. MetLife Investment Management LLC now owns 3,886 shares of the medical equipment provider’s stock valued at $174,000 after acquiring an additional 1,395 shares during the period. Rhumbline Advisers grew its position in shares of IRadimed by 14.4% during the 1st quarter. Rhumbline Advisers now owns 5,925 shares of the medical equipment provider’s stock valued at $266,000 after acquiring an additional 747 shares during the period. Dimensional Fund Advisors LP grew its position in shares of IRadimed by 18.3% during the 1st quarter. Dimensional Fund Advisors LP now owns 111,563 shares of the medical equipment provider’s stock valued at $5,003,000 after acquiring an additional 17,285 shares during the period. Finally, Aviva PLC bought a new position in IRadimed in the 1st quarter worth $632,000. 48.61% of the stock is currently owned by hedge funds and other institutional investors.

IRadimed Stock Performance

Shares of IRadimed stock opened at $42.74 on Thursday. The company has a market capitalization of $538.95 million, a P/E ratio of 33.13 and a beta of 0.88. The company has a fifty day moving average of $42.23 and a 200 day moving average of $45.40. IRadimed Co. has a fifty-two week low of $27.41 and a fifty-two week high of $51.04.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on IRMD shares. StockNews.com started coverage on shares of IRadimed in a report on Thursday, October 5th. They issued a “buy” rating for the company. Lake Street Capital upped their target price on shares of IRadimed from $55.00 to $60.00 in a report on Thursday, August 3rd.

Insiders Place Their Bets

In other IRadimed news, Director Anthony Vuoto sold 818 shares of the business’s stock in a transaction on Friday, November 10th. The shares were sold at an average price of $39.91, for a total value of $32,646.38. Following the sale, the director now owns 16,375 shares in the company, valued at approximately $653,526.25. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other IRadimed news, Director Anthony Vuoto sold 818 shares of the business’s stock in a transaction on Friday, November 10th. The shares were sold at an average price of $39.91, for a total value of $32,646.38. Following the sale, the director now owns 16,375 shares in the company, valued at approximately $653,526.25. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Roger E. Susi sold 5,000 shares of the company’s stock in a transaction dated Tuesday, October 24th. The shares were sold at an average price of $39.04, for a total transaction of $195,200.00. Following the sale, the chief executive officer now owns 257,950 shares in the company, valued at $10,070,368. The disclosure for this sale can be found here. Insiders have sold a total of 59,120 shares of company stock worth $2,559,056 in the last 90 days. 42.60% of the stock is currently owned by corporate insiders.

IRadimed Company Profile

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system.